Xiaobin Yu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Cells and Metastasis
Papers in
-
- Genomics and Chromatin Dynamics 3
- Cancer-related gene regulation 2
- Epigenetics and DNA Methylation 2
- Oncology 8
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Jianming Xu (10 shared papers)Jason T. Yustein (1 shared paper)Lan Liao (3 shared papers)Yixiang Xu (3 shared papers)Zhangwei Tong (3 shared papers)Li Qin (3 shared papers)Tao He (2 shared papers)Tao Zeng (3 shared papers)
- Journals
- Oncotarget (2 papers)European Food Research and Technology (1 paper)International Journal of Gynecological Cancer (1 paper)Breast Cancer Research (1 paper)Endocrine Related Cancer (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xiaobin Yu
19 papers receiving 339 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 52
- Oncology 78
- Immunology 51
- Aging 4
- Hepatology 16
Countries citing papers authored by Xiaobin Yu
This map shows the geographic impact of Xiaobin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Yu more than expected).
Fields of papers citing papers by Xiaobin Yu
This network shows the impact of papers produced by Xiaobin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Yu. The network helps show where Xiaobin Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 45 | |
| 2 | 2017 | 35 | |
| 3 | 2015 | 30 | |
| 4 | 2018 | 29 | |
| 5 | 2023 | 28 | |
| 6 | 2016 | 25 | |
| 7 | 2022 | 19 | |
| 8 | 2017 | 19 | |
| 9 | 2017 | 18 | |
| 10 | 2017 | 14 | |
| 11 | 2018 | 13 | |
| 12 | 2021 | 13 | |
| 13 | 2019 | 12 | |
| 14 | 2020 | 10 | |
| 15 | 2024 | 8 | |
| 16 | 2021 | 8 | |
| 17 | Inhibition of cell migration and invasion and promotion of cell apoptosis by overexpression of programmed cell death 4 (PDCD4) in cervical cancer Siha cells. | 2018 | 7 |
| 18 | 2022 | 5 | |
| 19 | 2020 | 1 | |
| 20 | 2025 | 0 |
About Xiaobin Yu
Xiaobin Yu is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Plant Science, having authored 20 papers that have together received 339 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Genomics and Chromatin Dynamics (3 papers), Polysaccharides and Plant Cell Walls (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer-related gene regulation (2 papers), HER2/EGFR in Cancer Research (2 papers), Estrogen and related hormone effects (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (52 citations), Oncology (78 citations), Immunology (51 citations), Aging (4 citations) and Hepatology (16 citations). Xiaobin Yu has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Jianming Xu, Jason T. Yustein, Lan Liao, Yixiang Xu, Zhangwei Tong, Li Qin, Tao He, Tao Zeng, Yang Yu and David M. Lonard. Their work appears in journals such as Oncotarget, European Food Research and Technology, International Journal of Gynecological Cancer, Breast Cancer Research and Endocrine Related Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.